SNCA and Parkinson disease: Parkinson’s disease (PD) is a motor disorder characterized by the progressive degeneration of the nigrostriatal dopaminergic (DAergic) pathway and the presence of α-synuclein aggregations in intracytoplasmatic inclusions called Lewy bodies1,2.